Immune Complexes as Therapy for Autoimmunity
Posted on September 28, 2009For several decades, intravenous Ig has been used as treatment for a variety of immune-related diseases, including immune thrombocytopenic purpura (ITP), autoimmune neuropathies, systemic lupus erythematosus, myasthenia gravis, Guillain-Barré syndrome, skin blistering ...Read more »PEM Friends Away Weekend
Posted on September 23, 2009The PEM Friends (UK) met in June for their annual Away Weekend hosted by Raymond and Carolyn Blain. Another really enjoyable and informative week-end was had by us all at Ashton-under-Lyne. It ...Read more »Debate Flaring Over Grants for Research
Posted on September 22, 2009WASHINGTON — Managers at the National Institutes of Health are increasingly ignoring the advice of scientific review panels and giving hundreds of millions of dollars a year to scientists whose projects are ...Read more »Benefit and Doubt in Vaccine Additive
Posted on September 22, 2009Are Americans obligated to use an unproven vaccine to help protect people in other countries from the flu pandemic? That is the crux of a debate over adjuvants — a class of ...Read more »Rituximab for Pemphigus: Data Still Favorable at 5 Years
Posted on September 22, 2009BUDAPEST, Hungary (EGMN) –Rituximab for the treatment of severe pemphigus continued to rack up impressive results in the 2-year extension of a landmark 3-year multicenter trial. Indeed, after 5 years of follow-up, 19 ...Read more »Fine-Tuning Drugs to Match Our Genes – What Are the Implications for Health Care Costs and Treatments?
Posted on September 15, 2009Pharmacogenomics is the study of how inherited variations in genes dictate a person’s reaction to a drug. In this 2004 to 2005 project, Louis F. Rossiter, Ph.D., and other researchers from the ...Read more »Robert Wood Johnson Foundation Awards $8.6-Million Grant to Kaiser Permanente to Develop Largest, Most Diverse U.S. Biobank
Posted on September 15, 2009The Robert Wood Johnson Foundation, through its Pioneer Portfolio, has awarded Kaiser Permanente $8.6 million to develop one of the world’s largest and most diverse repositories of genetic, environmental and health data. Scientists ...Read more »Improving Chronic Illness Care
Posted on September 15, 2009The use of organized chronic illness care management processes (CMPs) is discussed in this article. Cohort analysis of data from a national telephone survey conducted in 2000 and 2006 specifically looked at ...Read more »Centric Health Resources Identifies Ultra-Orphan Industry Trends, Impact of Risk Evaluation and Mitigation Strategies (REMS)
Posted on September 15, 2009Centric`s second annual ultra orphan conference, with Pharmaceutical Executive Magazine serving as media partner for 2009 event, offers industry guidance CHESTERFIELD, Mo. –(Business Wire)–Highlighting the role of specialty pharmaceuticals as the fastest growing ...Read more »Cyclophosphamide Trial Conclusions
Posted on September 10, 2009Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris. Abstract Background: In various case series, pulse therapy has shown good results ...Read more »
IPPF News
-
The latest Pemphigus & Pemphigoid Weekly! paper.li/healourskin/13… Thanks to @diabetesfuna @GlobalGenes @Immunotx_papers #raredisease #nord
-
Save the date! 2018 Annual Patient Conference Raleigh-Durham, NC October 12-14 Hosted by Donna Culton, MD (UNC Depa… twitter.com/i/web/status/9…
-
The latest Pemphigus & Pemphigoid Weekly! paper.li/healourskin/13… Thanks to @HSP_90 @RareDiseases @ThriveChiroFL #nord #progress
-
The latest Pemphigus & Pemphigoid Weekly! paper.li/healourskin/13… Thanks to @RareDiseases @TregCellRadar @ImmunePharma #raredisease #nord
-
Checkout the latest from PemPress: Strategies for Managing Pemphigus and Pemphigoid ift.tt/2GgsIux… twitter.com/i/web/status/9…